Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 3

2(28.6%)

Phase 2

1(14.3%)

7Total

N/A(4)

Phase 3(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04651790Phase 3Completed

Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults

Role: collaborator

NCT04992182Phase 2Unknown

Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster

Role: collaborator

NCT03459742Not ApplicableUnknown

Juntos Santiago: Gamification Strategy to Reduce Childhood Obesity in Schools in Santiago de Chile

Role: collaborator

NCT03514004Not ApplicableUnknown

Using Information and Communication Technologies to Prevent Suicide in Chile

Role: collaborator

NCT03197168Not ApplicableCompleted

Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among People With Mental Illness in Chile

Role: collaborator

NCT01916603Not ApplicableUnknown

Diet, Physical Activity and Breastfeeding Intervention on Maternal Nutrition, Offspring Growth and Development

Role: collaborator

NCT00243815Phase 3Completed

Use of Ibuprofen to Prevent IUD Site Effects

Role: collaborator

All 7 trials loaded